Bridgefront Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,292
| Closed | -$216K | – | 657 |
|
|
2024
Q1 | $216K | Sell |
15,292
-391
| -2% | -$5.52K | 0.16% | 298 |
|
|
2023
Q4 | $164K | Buy |
+15,683
| New | +$164K | 0.12% | 313 |
|
|
2022
Q4 | – | Sell |
-30,179
| Closed | -$244K | – | 513 |
|
|
2022
Q3 | $244K | Sell |
30,179
-16,508
| -35% | -$133K | 0.25% | 185 |
|
|
2022
Q2 | $351K | Buy |
+46,687
| New | +$351K | 0.39% | 93 |
|
|
2021
Q4 | – | Sell |
-26,293
| Closed | -$256K | – | 445 |
|
|
2021
Q3 | $256K | Buy |
+26,293
| New | +$256K | 0.27% | 179 |
|
|
2021
Q2 | – | Sell |
-25,947
| Closed | -$299K | – | 898 |
|
|
2021
Q1 | $299K | Buy |
+25,947
| New | +$299K | 0.09% | 429 |
|